Patents by Inventor Lena Hedstrom

Lena Hedstrom has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Crystalline forms
    Publication number: 20060287249
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid slate stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: August 22, 2006
    Publication date: December 21, 2006
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Crystalline forms
    Publication number: 20050153901
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: March 11, 2005
    Publication date: July 14, 2005
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • NEW CRYSTALLINE FORMS
    Publication number: 20050054579
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: May 20, 2002
    Publication date: March 10, 2005
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • Crystalline forms
    Publication number: 20030017992
    Abstract: There is provided EtO2C—CH2—(R)Cgl-Aze-Pab-OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl-Aze-Pab-OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: May 20, 2002
    Publication date: January 23, 2003
    Applicant: AstraZeneca AB
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson
  • New crystalline forms
    Publication number: 20010023244
    Abstract: There is provided EtO2C—CH2—(R)Cgl—Aze—Pab—OH, or a pharmaceutically-acceptable salt thereof, in a form which is substantially crystalline. It has been found that crystalline forms of EtO2C—CH2—(R)Cgl—Aze—Pab—OH have a high chemical and solid state stability when compared to amorphous forms of the compound.
    Type: Application
    Filed: January 4, 2001
    Publication date: September 20, 2001
    Applicant: Astra Aktiebolag
    Inventors: Daniel Edvardsson, Lena Hedstrom, Anita Lundblad, Ursula Pettersson